Adaptogenics Health 4:1 share consolidation
Analysis based on 6 articles · First reported Jul 08, 2026 · Last updated Jul 14, 2026
The share consolidation is a routine corporate action with minimal market impact. It may slightly improve the stock's per-share price but does not change the company's fundamentals.
Adaptogenics Health Corporation (CSE: ADPT) announced a 4:1 consolidation of its common shares, effective July 15, 2026, reducing outstanding shares from 16,397,701 to approximately 4,099,425. The consolidation was approved by the Canadian Securities Exchange and the company's board. No fractional shares will be issued; fractions >=0.5 are rounded up, others cancelled. The company's name and ticker remain unchanged. Adaptogenics is a Canadian nutraceutical company focused on functional mushroom products.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard